CentralCharts: Supercharge your portfolio with groundbreaking tools.

Elbit Systems Awarded Approximately $53 Million Contract to Supply Crossbow Unmanned Turreted Mortar Systems for a European Customer PR Newswire HAIFA, Israel, May 8, 2024 HAIFA, Israel , May 8, 2024 /PRNewswire/ -- Elbit Systems Ltd . (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced today that it was awarded a contract worth approximately $53 million to supply the Crossbow Unmanned Turreted 120mm Soft Recoil Mortar Systems to General Dynamics European Land Systems...

CONCENTRIC INTERIM REPORT JANUARY - MARCH 2024 PR Newswire REDDITCH, England, May 8, 2024 REDDITCH, England , May 8, 2024 /PRNewswire/ -- FIRST QUARTER 2024 Net sales: MSEK 1,003 (1,127) - down -11% year-on-year with no major foreign exchange movements. Compared to Q4 2023 sales are up +9% in constant currency. Operating income : Operating income was MSEK 137 (181) generating an Operating margin of 13.7% (16.1), up +1.6% from Operating margin before items affecting comparability of 12.1%...

VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation PR Newswire SINGAPORE, May 8, 2024 Empowering key ecosystem players to find each other easily and work together SINGAPORE , May 8, 2024 /PRNewswire/ -- VentureBlick announces the launch of Discovery, a groundbreaking networking platform designed to connect healthcare innovators, advisors, investors, distributors, partners, and service providers worldwide. Healthcare innovation is often associated...

ABIVAX Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 08-May-2024 / 08:30 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 PARIS, France, May 8,...

EQS-News: Wolftank-Adisa Holding AG / Key word(s): Incoming Orders/Contract Wolftank Group secures two new major orders in Italy with a total value of EUR 6.7 million 08.05.2024 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. Wolftank Group secures two new major orders in Italy with a total value of EUR 6.7 million Wolftank Group (Wolftank-Adisa Holding AG, ISIN: AT0000A25NJ6), a specialist in environmental and energy technologies with a focus on emission...

Securitas AB Interim Report Q1 2024 January-March PR Newswire STOCKHOLM, May 8, 2024 STOCKHOLM , May 8, 2024 /PRNewswire/ -- January–March 2024 Total sales MSEK 39 260 (37 751) Organic sales growth 7 percent (12) Real sales growth within technology and solutions 7 percent (77) Operating income before amortization MSEK 2 357 (2 180) Operating margin 6.0 percent (5.8) Earnings per share SEK 1.84 (1.66) Earnings per share before IAC, SEK 2.12 (2.03) Net debt/EBITDA ratio 2.9 (3.3*) Cash flow from...

Securitas AB Interim Report Q1 2024 January-March PR Newswire STOCKHOLM, May 8, 2024 STOCKHOLM , May 8, 2024 /PRNewswire/ -- January–March 2024 Total sales MSEK 39 260 (37 751) Organic sales growth 7 percent (12) Real sales growth within technology and solutions 7 percent (77) Operating income before amortization MSEK 2 357 (2 180) Operating margin 6.0 percent (5.8) Earnings per share SEK 1.84 (1.66) Earnings per share before IAC, SEK 2.12 (2.03) Net debt/EBITDA ratio 2.9 (3.3*) Cash flow from...